| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.472 | 5.326 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 4.473 | 5.424 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 5.142 | 7.523 | - | 2.000 | 1.109 | 1.526 | 65 | 0 | 16 | 1.801 |
| Gross Profit/Loss - EUR | -669 | -2.099 | - | -2.000 | -1.109 | -1.526 | -65 | 0 | -16 | -1.801 |
| Net Profit/Loss - EUR | -803 | -2.259 | - | -2.000 | -1.109 | -1.526 | -65 | 0 | -16 | -1.801 |
| Employees | 1 | 1 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Kary Bio-Masă Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 536 | 435 | - | 286 | 214 | 145 | 79 | 79 | 63 | 63 |
| Current Assets | 10.855 | 11.933 | - | 7.280 | 6.097 | 1.641 | 1.603 | 1.608 | 1.603 | 237 |
| Inventories | 792 | 2.613 | - | 1.711 | 1.677 | 233 | 227 | 228 | 227 | 226 |
| Receivables | 430 | 243 | - | 355 | 349 | 0 | 0 | 0 | 0 | 0 |
| Cash | 9.633 | 9.077 | - | 5.214 | 4.071 | 1.409 | 1.376 | 1.380 | 1.376 | 10 |
| Shareholders Funds | -4.421 | -6.635 | - | -11.614 | -12.497 | -13.787 | -13.546 | -13.588 | -13.562 | -15.288 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 15.812 | 19.003 | - | 19.180 | 18.808 | 15.573 | 15.228 | 15.275 | 15.229 | 15.587 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "220 - 220" | |||||||||
| CAEN Financial Year |
220
|
|||||||||
Comments - Kary Bio-Masă Srl